Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections
Filamentous tau inclusions are hallmarks of Alzheimer’s disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024–1037, 2013 ) tha...
Saved in:
Published in | Acta neuropathologica Vol. 130; no. 3; pp. 349 - 362 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.09.2015
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0001-6322 1432-0533 1432-0533 |
DOI | 10.1007/s00401-015-1458-4 |
Cover
Abstract | Filamentous tau inclusions are hallmarks of Alzheimer’s disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024–1037,
2013
) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6–12 months post-injection. However, the spreading pattern of tau pathology observed in our LC-injected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. |
---|---|
AbstractList | Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024-1037, 2013) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6-12 months post-injection. However, the spreading pattern of tau pathology observed in our LC-injected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration.Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024-1037, 2013) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6-12 months post-injection. However, the spreading pattern of tau pathology observed in our LC-injected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024-1037, 2013) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6-12 months post-injection. However, the spreading pattern of tau pathology observed in our LC-injected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. Filamentous tau inclusions are hallmarks of Alzheimer’s disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024–1037, 2013 ) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6–12 months post-injection. However, the spreading pattern of tau pathology observed in our LC-injected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024-1037, 2013) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6-12 months post-injection. However, the spreading pattern of tau pathology observed in our LC-injected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. Filamentous tau inclusions are hallmarks of Alzheimer’s disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed [ 25 ] that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle bearing neurons gradually cleared tau pathology by 6–12 months post-injection. However, the spreading pattern of tau pathology observed in our LC-injected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024-1037, 2013) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6-12 months post-injection. However, the spreading pattern of tau pathology observed in our LCinjected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the cell-to-cell propagation of tau pathology in the progression of tauopathies. We recently showed (Iba et al., J Neurosci 33:1024-1037, 2013) that inoculation of preformed synthetic tau fibrils (tau PFFs) into the hippocampus of young transgenic (Tg) mice (PS19) overexpressing human P301S mutant tau induced robust tau pathology in anatomically connected brain regions including the locus coeruleus (LC). Since Braak and colleagues hypothesized that the LC is the first brain structure to develop tau lesions and since LC has widespread connections throughout the CNS, LC neurons could be the critical initiators of the stereotypical spreading of tau pathology through connectome-dependent transmission of pathological tau in AD. Here, we report that injections of tau PFFs into the LC of PS19 mice induced propagation of tau pathology to major afferents and efferents of the LC. Notably, tau pathology propagated along LC efferent projections was localized not only to axon terminals but also to neuronal perikarya, suggesting transneuronal transfer of templated tau pathology to neurons receiving LC projections. Further, brainstem neurons giving rise to major LC afferents also developed perikaryal tau pathology. Surprisingly, while tangle-bearing neurons degenerated in the LC ipsilateral to the injection site starting 6 months post-injection, no neuron loss was seen in the contralateral LC wherein tangle-bearing neurons gradually cleared tau pathology by 6-12 months post-injection. However, the spreading pattern of tau pathology observed in our LCinjected mice is different from that in AD brains since hippocampus and entorhinal cortex, which are affected in early stages of AD, were largely spared of tau inclusions in our model. Thus, while our study tested critical aspects of the Braak hypothesis of tau pathology spread, this novel mouse model provides unique opportunities to elucidate mechanisms underlying the selective vulnerability of neurons to acquire tau pathology and succumb to or resist tau-mediated neurodegeneration. Keywords Transmission of misfolded tau * Alzheimer's disease * Mouse models of tauopathies * Locus coeruleus |
Audience | Academic |
Author | McBride, Jennifer D. Zhang, Bin Iba, Michiyo Trojanowski, John Q. Lee, Virginia M.-Y. Guo, Jing L. |
Author_xml | – sequence: 1 givenname: Michiyo surname: Iba fullname: Iba, Michiyo organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine – sequence: 2 givenname: Jennifer D. surname: McBride fullname: McBride, Jennifer D. organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine – sequence: 3 givenname: Jing L. surname: Guo fullname: Guo, Jing L. organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine – sequence: 4 givenname: Bin surname: Zhang fullname: Zhang, Bin organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine – sequence: 5 givenname: John Q. surname: Trojanowski fullname: Trojanowski, John Q. organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine – sequence: 6 givenname: Virginia M.-Y. surname: Lee fullname: Lee, Virginia M.-Y. email: vmylee@upenn.edu organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26150341$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1u1DAUhSNURKeFB2CDLLEpixT_JtMNUjXiTxoJJMracpzrGY8y9mAnRbPjNXgMXokn4YaZVtMKEMoice53jq7vPSfFUYgBiuIpo-eM0vplplRSVlKmSibVtJQPigmTgpdUCXFUTCjFaiU4Py5Ocl7hiddSPSqOecUUFZJNih9XZiAb0y9jFxdbkjcJTEt8IB8_sQvSY7FPJuQFBG_J2lsgLnZd_OrDgnTRDpnYCGnoAL_O5rMXKF2B7X0MmURH8jb0S-hRO1o53yTfZeIzaaGHtPYBWtJsCTJkPvv57XsmxjlIEHpiQkvg5mBjCHvbx8VDZ7oMT_bv0-Lzm9dXs3fl_MPb97PLeWlrWvUlg4o7q5ysWi4lXoo1qq4YmLoxzNbcNK1worVOMGNxRhVnDTDjBAdRUzDitHi1890MzRpai20k0-lN8muTtjoar-9Wgl_qRbzWUklVTRUanO0NUvwyQO712mcLXWcCxCFrVuM6aikV-w-UqlqIqZCIPr-HruKQAk7iNyUxF4fUwnSgfXARW7Sjqb6UYsppLS8EUud_oPBpAVeNWXMe_98RPDucye0wbvKEANsBNsWcE7hbhFE9ZlbvMqsxs3rMrB57re9prO_NuGvsxnf_VPKdEmOLgYR0MIu_in4BPIgCQg |
CitedBy_id | crossref_primary_10_3390_ijms22031273 crossref_primary_10_3389_fneur_2020_590199 crossref_primary_10_7554_eLife_58744 crossref_primary_10_1017_S135561771700100X crossref_primary_10_1007_s00401_022_02417_4 crossref_primary_10_3233_JAD_160371 crossref_primary_10_1126_sciadv_aaw6404 crossref_primary_10_15252_emmm_201607054 crossref_primary_10_3389_fnagi_2022_1026260 crossref_primary_10_1016_j_celrep_2021_108843 crossref_primary_10_1016_j_neubiorev_2020_01_026 crossref_primary_10_3389_fneur_2017_00692 crossref_primary_10_1016_j_npbr_2016_01_001 crossref_primary_10_1016_j_jmb_2020_05_027 crossref_primary_10_1002_acn3_50818 crossref_primary_10_1080_19336896_2018_1545524 crossref_primary_10_1186_s13024_022_00527_x crossref_primary_10_1007_s00401_020_02253_4 crossref_primary_10_15252_embj_201593489 crossref_primary_10_1186_s40478_024_01849_1 crossref_primary_10_1089_neu_2018_6348 crossref_primary_10_1186_s13195_019_0511_2 crossref_primary_10_1007_s11910_023_01324_9 crossref_primary_10_1111_jnc_70021 crossref_primary_10_1007_s00018_018_2854_4 crossref_primary_10_3233_JAD_160361 crossref_primary_10_1016_j_neurobiolaging_2018_07_007 crossref_primary_10_2174_1566524019666190917125917 crossref_primary_10_1016_j_brainres_2017_12_027 crossref_primary_10_1126_sciadv_abd1327 crossref_primary_10_3389_fnagi_2017_00187 crossref_primary_10_1016_j_nbd_2018_07_003 crossref_primary_10_1126_scitranslmed_aat8462 crossref_primary_10_3389_fnmol_2019_00107 crossref_primary_10_1007_s00401_023_02600_1 crossref_primary_10_1523_JNEUROSCI_1700_18_2018 crossref_primary_10_1155_2017_6031478 crossref_primary_10_1093_braincomms_fcad147 crossref_primary_10_3390_v11030261 crossref_primary_10_1016_j_jpsychires_2020_01_018 crossref_primary_10_1515_bmc_2018_0001 crossref_primary_10_3390_life11090938 crossref_primary_10_1007_s00401_018_1891_2 crossref_primary_10_1186_s12974_023_02853_3 crossref_primary_10_1016_j_tma_2023_11_001 crossref_primary_10_3389_fnagi_2022_949361 crossref_primary_10_1007_s00401_021_02315_1 crossref_primary_10_1007_s11910_020_01087_7 crossref_primary_10_1016_j_neuron_2016_01_026 crossref_primary_10_1038_s12276_020_00494_7 crossref_primary_10_1111_bpa_13028 crossref_primary_10_1186_s40478_020_01012_6 crossref_primary_10_1016_j_celrep_2021_109037 crossref_primary_10_1111_ene_15556 crossref_primary_10_1074_jbc_RA119_009674 crossref_primary_10_1523_JNEUROSCI_1230_17_2017 crossref_primary_10_3390_biomedicines10071550 crossref_primary_10_1021_acschemneuro_0c00531 crossref_primary_10_1093_brain_awx371 crossref_primary_10_1248_yakushi_18_00165_6 crossref_primary_10_3389_fnmol_2018_00254 crossref_primary_10_1002_1873_3468_70022 crossref_primary_10_1038_s41467_017_01575_4 crossref_primary_10_1089_brain_2020_0841 crossref_primary_10_1111_nan_12440 crossref_primary_10_1126_scitranslmed_abj2511 crossref_primary_10_1146_annurev_pharmtox_040323_031929 crossref_primary_10_3390_antiox14030255 crossref_primary_10_1016_j_jalz_2016_06_2362 crossref_primary_10_3390_ijms25116222 crossref_primary_10_1093_brain_awv236 crossref_primary_10_1016_j_neubiorev_2021_10_030 crossref_primary_10_1155_2017_7829507 crossref_primary_10_1016_j_nbd_2019_03_010 crossref_primary_10_15252_embj_201899871 crossref_primary_10_1084_jem_20160833 crossref_primary_10_3390_pharmaceutics15092364 crossref_primary_10_3390_ijms21228630 crossref_primary_10_4103_0366_6999_220313 crossref_primary_10_1016_j_neuroimage_2022_119658 crossref_primary_10_1016_j_bbadis_2024_167204 crossref_primary_10_1016_j_jalz_2016_06_006 crossref_primary_10_3390_biomedicines11041004 crossref_primary_10_1016_j_pharmthera_2016_11_010 crossref_primary_10_1186_s40478_018_0637_7 crossref_primary_10_1007_s12640_017_9765_2 crossref_primary_10_1038_s41467_018_05075_x crossref_primary_10_1002_jnr_24718 crossref_primary_10_1111_jnc_15040 crossref_primary_10_15252_embj_2020106320 crossref_primary_10_1038_s41380_024_02664_9 crossref_primary_10_1093_jnen_nlab087 crossref_primary_10_1002_jcsm_13312 crossref_primary_10_1016_j_tins_2018_01_010 crossref_primary_10_3389_fneur_2020_590754 crossref_primary_10_1074_jbc_RA119_007527 crossref_primary_10_1093_brain_awac202 crossref_primary_10_3389_fnana_2017_00080 crossref_primary_10_1186_s40478_017_0459_z crossref_primary_10_1242_dmm_050858 crossref_primary_10_3233_JAD_231337 crossref_primary_10_1038_s43587_024_00626_y crossref_primary_10_1007_s00401_018_1937_5 crossref_primary_10_1007_s00702_021_02338_8 crossref_primary_10_1016_j_ymthe_2020_10_007 crossref_primary_10_1523_JNEUROSCI_0275_18_2018 crossref_primary_10_1002_glia_24160 crossref_primary_10_3389_fneur_2017_00653 crossref_primary_10_1016_j_jbc_2021_100636 crossref_primary_10_1016_j_biopsych_2019_09_019 crossref_primary_10_1016_j_biopsycho_2024_108847 crossref_primary_10_3389_fneur_2018_01159 crossref_primary_10_1523_ENEURO_0004_24_2024 crossref_primary_10_1186_s40478_024_01907_8 crossref_primary_10_1016_j_celrep_2018_04_056 crossref_primary_10_1186_s40478_017_0488_7 crossref_primary_10_1038_s41467_024_52173_0 crossref_primary_10_1523_JNEUROSCI_1828_22_2023 crossref_primary_10_3233_JAD_220276 crossref_primary_10_1016_j_neuroimage_2021_118008 crossref_primary_10_1073_pnas_2013552117 crossref_primary_10_1093_brain_awy193 crossref_primary_10_15252_embj_201592748 crossref_primary_10_1016_j_alcohol_2022_08_008 crossref_primary_10_1007_s00401_019_02108_7 crossref_primary_10_1038_s42003_025_07575_1 crossref_primary_10_1016_j_neuroimage_2019_01_007 crossref_primary_10_3389_fnagi_2020_00056 crossref_primary_10_1016_j_neuron_2024_12_015 crossref_primary_10_1186_s40478_018_0541_1 crossref_primary_10_3390_biom10071079 crossref_primary_10_3390_biomedicines10020241 crossref_primary_10_1111_bpa_12778 crossref_primary_10_1016_j_brainresbull_2019_08_007 crossref_primary_10_1016_j_pneurobio_2018_03_001 crossref_primary_10_1186_s40035_022_00293_2 crossref_primary_10_1016_j_neuroscience_2022_06_025 crossref_primary_10_3233_JAD_221279 crossref_primary_10_1016_j_nbd_2020_105011 crossref_primary_10_3233_JAD_150704 crossref_primary_10_1007_s00401_020_02210_1 crossref_primary_10_1111_ner_13305 crossref_primary_10_1007_s11481_017_9768_z crossref_primary_10_1016_j_bpsc_2018_07_012 crossref_primary_10_1038_s41593_018_0238_6 crossref_primary_10_1016_j_pneurobio_2022_102306 crossref_primary_10_1089_brain_2020_0905 crossref_primary_10_1016_j_neubiorev_2016_12_020 crossref_primary_10_1038_s41374_019_0197_x crossref_primary_10_1038_s41467_020_20322_w crossref_primary_10_1186_s40478_016_0300_0 crossref_primary_10_1007_s00401_024_02749_3 crossref_primary_10_1177_23982128231191046 crossref_primary_10_1073_pnas_1616344113 crossref_primary_10_1074_jbc_M117_815357 crossref_primary_10_1155_2019_6981268 crossref_primary_10_1186_s40478_024_01748_5 crossref_primary_10_3390_ijms23094789 crossref_primary_10_1016_j_jtbi_2022_111074 crossref_primary_10_1038_nature20412 crossref_primary_10_1186_s40478_019_0725_3 crossref_primary_10_1186_s13024_017_0215_7 crossref_primary_10_1002_alz_14426 crossref_primary_10_1093_brain_aww230 crossref_primary_10_1016_j_neurobiolaging_2022_11_002 crossref_primary_10_1016_j_pneurobio_2025_102750 crossref_primary_10_1016_j_brainresbull_2022_10_006 crossref_primary_10_1038_srep44102 crossref_primary_10_1007_s00401_024_02771_5 |
Cites_doi | 10.1016/j.febslet.2013.01.051 10.1074/jbc.M808759200 10.1016/0006-8993(95)00061-T 10.1097/00005072-199902000-00008 10.1146/annurev.neuro.28.061604.135709 10.1146/annurev.neuro.24.1.1121 10.1126/science.1113694 10.1016/j.neuron.2011.11.033 10.1021/bi400866w 10.1523/JNEUROSCI.2642-12.2013 10.1007/s00401-015-1413-4 10.1007/s00401-014-1373-0 10.1002/cne.901780102 10.1073/pnas.1318807111 10.1523/JNEUROSCI.4922-11.2012 10.1073/pnas.1301175110 10.2353/ajpath.2010.100346 10.1038/ncb1901 10.1007/s00401-012-0987-3 10.1016/S0165-0173(03)00143-7 10.1007/s00401-010-0789-4 10.1007/s00401-014-1254-6 10.1038/nn.2682 10.1146/annurev.ne.02.030179.000553 10.1371/journal.pone.0031302 10.1016/0361-9230(79)90037-6 10.1126/science.1062382 10.1016/0361-9230(79)90034-0 10.1016/j.nbd.2014.08.032 10.1038/nm.3457 10.1016/j.neuron.2007.01.010 10.1074/jbc.M110.209296 10.1016/0022-510X(82)90155-1 10.1038/nrn3887 10.1038/nrn2194 10.1097/NEN.0b013e318232a379 10.1016/0306-4522(94)00481-J 10.1016/S0006-8993(98)00441-7 10.1007/s00401-014-1380-1 10.1212/WNL.42.3.631 10.1126/science.3775363 10.1007/BF00308809 10.1152/physrev.1983.63.3.844 |
ContentType | Journal Article |
Copyright | Springer-Verlag Berlin Heidelberg 2015 COPYRIGHT 2015 Springer |
Copyright_xml | – notice: Springer-Verlag Berlin Heidelberg 2015 – notice: COPYRIGHT 2015 Springer |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7U9 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ H94 K9. M0S M1P M2M PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1007/s00401-015-1458-4 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Psychology Database (ProQuest) Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Neurosciences Abstracts ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-0533 |
EndPage | 362 |
ExternalDocumentID | PMC4545685 3782331091 A438207493 26150341 10_1007_s00401_015_1458_4 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States--US Virginia |
GeographicLocations_xml | – name: United States--US – name: Virginia |
GrantInformation_xml | – fundername: the Paula C. Schmerler Fund for Alzheimer’s Research – fundername: National Institutes of Health Grant – fundername: National Institutes of Health Grant grantid: AG17586 – fundername: the Marian S. Ware Alzheimer Program Cure Alzheimer’s Fund – fundername: the Eleanor Margaret Kurtz Endowed Fund – fundername: the Karen Cohen Segal and Christopher S. Segal Alzheimer Drug Discovery Initiative Fund – fundername: the Barrist Neurodegenerative Disease Research Fund – fundername: the Mary Rasmus Endowed Fund for Alzheimer’s Research – fundername: NIA NIH HHS grantid: P01 AG017586 – fundername: NIA NIH HHS grantid: AG17586 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 23M 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DWQXO EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IHE IHR IJ- IKXTQ IMOTQ INH INR IPY ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M2M M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 X7M YLTOR Z45 Z7U Z7V Z81 Z82 Z83 Z87 Z8O Z8P Z8U Z8V Z8W Z91 ZGI ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY AEIIB PMFND 7TK 7U9 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c706t-1e62fc5f46d244ead1b5761ea7ba1c72abd3f3dcf31ac632621be1af32e370ea3 |
IEDL.DBID | 7X7 |
ISSN | 0001-6322 1432-0533 |
IngestDate | Thu Aug 21 18:35:15 EDT 2025 Thu Sep 04 18:40:10 EDT 2025 Thu Sep 04 17:28:29 EDT 2025 Sat Aug 16 10:12:43 EDT 2025 Tue Jun 17 20:59:03 EDT 2025 Tue Jun 10 20:25:21 EDT 2025 Mon Jul 21 06:03:04 EDT 2025 Tue Jul 01 03:38:11 EDT 2025 Thu Apr 24 22:58:01 EDT 2025 Fri Feb 21 02:35:56 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Mouse models of tauopathies Alzheimer’s disease Transmission of misfolded tau Locus coeruleus |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c706t-1e62fc5f46d244ead1b5761ea7ba1c72abd3f3dcf31ac632621be1af32e370ea3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://doi.org/10.1007/s00401-015-1458-4 |
PMID | 26150341 |
PQID | 1705400734 |
PQPubID | 49178 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4545685 proquest_miscellaneous_1712774451 proquest_miscellaneous_1705733834 proquest_journals_1705400734 gale_infotracmisc_A438207493 gale_infotracacademiconefile_A438207493 pubmed_primary_26150341 crossref_primary_10_1007_s00401_015_1458_4 crossref_citationtrail_10_1007_s00401_015_1458_4 springer_journals_10_1007_s00401_015_1458_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-09-01 |
PublicationDateYYYYMMDD | 2015-09-01 |
PublicationDate_xml | – month: 09 year: 2015 text: 2015-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationSubtitle | Pathology and Mechanisms of Neurological Disease |
PublicationTitle | Acta neuropathologica |
PublicationTitleAbbrev | Acta Neuropathol |
PublicationTitleAlternate | Acta Neuropathol |
PublicationYear | 2015 |
Publisher | Springer Berlin Heidelberg Springer Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer – name: Springer Nature B.V |
References | Liu, Drouet, Wu, Witter, Small, Clelland, Duff (CR30) 2012; 7 Braak, Braak (CR9) 1991; 82 Carter, Yizhar, Chikahisa, Nguyen, Adamantidis, Nishino, Deisseroth, de Lecea (CR13) 2010; 13 Stancu, Vasconcelos, Ris, Wang, Villers, Peeraer, Buist, Terwel, Baatsen, Oyelami (CR39) 2015; 129 Guo, Lee (CR23) 2011; 286 Frost, Jacks, Diamond (CR20) 2009; 284 Peeraer, Bottelbergs, Van Kolen, Stancu, Vasconcelos, Mahieu, Duytschaever, Ver Donck, Torremans, Sluydts (CR37) 2015; 73 Iba, Guo, McBride, Zhang, Trojanowski, Lee (CR25) 2013; 33 Hurtado, Molina-Porcel, Iba, Aboagye, Paul, Trojanowski, Lee (CR24) 2010; 177 Irwin, Cairns, Grossman, McMillan, Lee, Van Deerlin, Lee, Trojanowski (CR26) 2015; 129 Moore, Bloom (CR32) 1979; 2 CR36 Bobinski, Wegiel, Tarnawski, de Leon, Reisberg, Miller, Wisniewski (CR7) 1998; 799 Ahmed, Cooper, Murray, Garn, McNaughton, Clarke, Parhizkar, Ward, Cavallini, Jackson (CR1) 2014; 127 Guo, Lee (CR22) 2013; 587 Wittmann, Wszolek, Shulman, Salvaterra, Lewis, Hutton, Feany (CR42) 2001; 293 Morozova, March, Robinson, Colby (CR34) 2013; 52 Wilcock, Esiri (CR41) 1982; 56 Ballatore, Lee, Trojanowski (CR5) 2007; 8 Clavaguera, Bolmont, Crowther, Abramowski, Frank, Probst, Fraser, Stalder, Beibel, Staufenbiel (CR16) 2009; 11 Clavaguera, Akatsu, Fraser, Crowther, Frank, Hench, Probst, Winkler, Reichwald, Staufenbiel (CR15) 2013; 110 Foote, Bloom, Aston-Jones (CR19) 1983; 63 Clavier (CR17) 1979; 4 Braak, Thal, Ghebremedhin, Del Tredici (CR11) 2011; 70 Braak, Del Tredici (CR10) 2011; 121 Santacruz, Lewis, Spires, Paulson, Kotilinek, Ingelsson, Guimaraes, DeTure, Ramsden, McGowan (CR38) 2005; 309 de Calignon, Polydoro, Suarez-Calvet, William, Adamowicz, Kopeikina, Pitstick, Sahara, Ashe, Carlson (CR18) 2012; 73 Guo, Lee (CR21) 2014; 20 Brettschneider, Del Tredici, Lee, Trojanowski (CR12) 2015; 16 Berridge, Waterhouse (CR6) 2003; 42 Yoshiyama, Higuchi, Zhang, Huang, Iwata, Saido, Maeda, Suhara, Trojanowski, Lee (CR43) 2007; 53 Aston-Jones, Cohen (CR3) 2005; 28 Kuchibhotla, Wegmann, Kopeikina, Hawkes, Rudinskiy, Andermann, Spires-Jones, Bacskai, Hyman (CR28) 2014; 111 Van der Jeugd, Hochgrafe, Ahmed, Decker, Sydow, Hofmann, Wu, Messing, Balschun, D’Hooge (CR40) 2012; 123 Morgane, Jacobs (CR33) 1979; 4 Arriagada, Growdon, Hedley-Whyte, Hyman (CR2) 1992; 42 Boluda, Iba, Zhang, Raible, Lee, Trojanowski (CR8) 2015; 129 Luppi, Aston-Jones, Akaoka, Chouvet, Jouvet (CR31) 1995; 65 Cedarbaum, Aghajanian (CR14) 1978; 178 Lee, Goedert, Trojanowski (CR29) 2001; 24 Zhang, Carroll, Trojanowski, Yao, Iba, Potuzak, Hogan, Xie, Ballatore, Smith (CR44) 2012; 32 Aston-Jones, Ennis, Pieribone, Nickell, Shipley (CR4) 1986; 234 Kenessey, Yen, Liu, Yang, Dunlop (CR27) 1995; 675 Morsch, Simon, Coleman (CR35) 1999; 58 H Braak (1458_CR11) 2011; 70 F Clavaguera (1458_CR16) 2009; 11 1458_CR36 Y Yoshiyama (1458_CR43) 2007; 53 PH Luppi (1458_CR31) 1995; 65 A de Calignon (1458_CR18) 2012; 73 SL Foote (1458_CR19) 1983; 63 B Frost (1458_CR20) 2009; 284 A Kenessey (1458_CR27) 1995; 675 RY Moore (1458_CR32) 1979; 2 B Zhang (1458_CR44) 2012; 32 G Aston-Jones (1458_CR3) 2005; 28 PJ Morgane (1458_CR33) 1979; 4 IC Stancu (1458_CR39) 2015; 129 G Aston-Jones (1458_CR4) 1986; 234 F Clavaguera (1458_CR15) 2013; 110 DE Hurtado (1458_CR24) 2010; 177 JL Guo (1458_CR23) 2011; 286 KV Kuchibhotla (1458_CR28) 2014; 111 L Liu (1458_CR30) 2012; 7 JL Guo (1458_CR21) 2014; 20 R Morsch (1458_CR35) 1999; 58 Z Ahmed (1458_CR1) 2014; 127 C Ballatore (1458_CR5) 2007; 8 DJ Irwin (1458_CR26) 2015; 129 K Santacruz (1458_CR38) 2005; 309 OA Morozova (1458_CR34) 2013; 52 A Van der Jeugd (1458_CR40) 2012; 123 VM Lee (1458_CR29) 2001; 24 GK Wilcock (1458_CR41) 1982; 56 ME Carter (1458_CR13) 2010; 13 CW Wittmann (1458_CR42) 2001; 293 S Boluda (1458_CR8) 2015; 129 H Braak (1458_CR10) 2011; 121 RM Clavier (1458_CR17) 1979; 4 CW Berridge (1458_CR6) 2003; 42 H Braak (1458_CR9) 1991; 82 PV Arriagada (1458_CR2) 1992; 42 J Brettschneider (1458_CR12) 2015; 16 E Peeraer (1458_CR37) 2015; 73 M Bobinski (1458_CR7) 1998; 799 JM Cedarbaum (1458_CR14) 1978; 178 JL Guo (1458_CR22) 2013; 587 M Iba (1458_CR25) 2013; 33 25534024 - Acta Neuropathol. 2015 Feb;129(2):221-37 11520930 - Annu Rev Neurosci. 2001;24:1121-59 16020737 - Science. 2005 Jul 15;309(5733):476-81 22312444 - PLoS One. 2012;7(2):e31302 23690619 - Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40 9666111 - Brain Res. 1998 Jul 13;799(1):156-8 19282288 - J Biol Chem. 2009 May 8;284(19):12845-52 19503072 - Nat Cell Biol. 2009 Jul;11(7):909-13 20802182 - Am J Pathol. 2010 Oct;177(4):1977-88 22002422 - J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9 22365544 - Neuron. 2012 Feb 23;73(4):685-97 24033133 - Biochemistry. 2013 Oct 8;52(40):6960-7 24504409 - Nat Med. 2014 Feb;20(2):130-8 25549971 - Acta Neuropathol. 2015 Apr;129(4):469-91 1759558 - Acta Neuropathol. 1991;82(4):239-59 24531916 - Acta Neuropathol. 2014 May;127(5):667-83 7175555 - J Neurol Sci. 1982 Nov;56(2-3):343-56 24368848 - Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):510-4 22423084 - J Neurosci. 2012 Mar 14;32(11):3601-11 3775363 - Science. 1986 Nov 7;234(4777):734-7 487203 - Brain Res Bull. 1979 Jul-Aug;4(4):497-504 21170538 - Acta Neuropathol. 2011 Feb;121(2):171-81 7753394 - Neuroscience. 1995 Mar;65(1):119-60 22532069 - Acta Neuropathol. 2012 Jun;123(6):787-805 12668290 - Brain Res Brain Res Rev. 2003 Apr;42(1):33-84 23395797 - FEBS Lett. 2013 Mar 18;587(6):717-23 7796127 - Brain Res. 1995 Mar 27;675(1-2):183-9 25862635 - Acta Neuropathol. 2015 Jun;129(6):875-94 6308694 - Physiol Rev. 1983 Jul;63(3):844-914 23325240 - J Neurosci. 2013 Jan 16;33(3):1024-37 21037585 - Nat Neurosci. 2010 Dec;13(12):1526-33 226233 - Brain Res Bull. 1979 Jul-Aug;4(4):519-34 17684513 - Nat Rev Neurosci. 2007 Sep;8(9):663-72 11408621 - Science. 2001 Jul 27;293(5530):711-4 632368 - J Comp Neurol. 1978 Mar 1;178(1):1-16 21372138 - J Biol Chem. 2011 Apr 29;286(17):15317-31 25220759 - Neurobiol Dis. 2015 Jan;73:83-95 1549228 - Neurology. 1992 Mar;42(3 Pt 1):631-9 17270732 - Neuron. 2007 Feb 1;53(3):337-51 231924 - Annu Rev Neurosci. 1979;2:113-68 10029101 - J Neuropathol Exp Neurol. 1999 Feb;58(2):188-97 16022602 - Annu Rev Neurosci. 2005;28:403-50 25588378 - Nat Rev Neurosci. 2015 Feb;16(2):109-20 |
References_xml | – volume: 587 start-page: 717 year: 2013 end-page: 723 ident: CR22 article-title: Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau publication-title: FEBS Lett doi: 10.1016/j.febslet.2013.01.051 – volume: 284 start-page: 12845 year: 2009 end-page: 12852 ident: CR20 article-title: Propagation of tau misfolding from the outside to the inside of a cell publication-title: J Biol Chem doi: 10.1074/jbc.M808759200 – volume: 675 start-page: 183 year: 1995 end-page: 189 ident: CR27 article-title: Detection of -aspartate in tau proteins associated with Alzheimer paired helical filaments publication-title: Brain Res doi: 10.1016/0006-8993(95)00061-T – volume: 58 start-page: 188 year: 1999 end-page: 197 ident: CR35 article-title: Neurons may live for decades with neurofibrillary tangles publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199902000-00008 – volume: 28 start-page: 403 year: 2005 end-page: 450 ident: CR3 article-title: An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.28.061604.135709 – volume: 24 start-page: 1121 year: 2001 end-page: 1159 ident: CR29 article-title: Neurodegenerative tauopathies publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.24.1.1121 – volume: 309 start-page: 476 year: 2005 end-page: 481 ident: CR38 article-title: Tau suppression in a neurodegenerative mouse model improves memory function publication-title: Science doi: 10.1126/science.1113694 – volume: 73 start-page: 685 year: 2012 end-page: 697 ident: CR18 article-title: Propagation of tau pathology in a model of early Alzheimer’s disease publication-title: Neuron doi: 10.1016/j.neuron.2011.11.033 – volume: 52 start-page: 6960 year: 2013 end-page: 6967 ident: CR34 article-title: Conformational features of tau fibrils from Alzheimer’s disease brain are faithfully propagated by unmodified recombinant protein publication-title: Biochemistry doi: 10.1021/bi400866w – volume: 33 start-page: 1024 year: 2013 end-page: 1037 ident: CR25 article-title: Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer’s-like tauopathy publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2642-12.2013 – volume: 129 start-page: 875 year: 2015 end-page: 894 ident: CR39 article-title: Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice publication-title: Acta Neuropathol doi: 10.1007/s00401-015-1413-4 – volume: 129 start-page: 221 year: 2015 end-page: 237 ident: CR8 article-title: Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1373-0 – volume: 178 start-page: 1 year: 1978 end-page: 16 ident: CR14 article-title: Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique publication-title: J Comp Neurol doi: 10.1002/cne.901780102 – volume: 111 start-page: 510 year: 2014 end-page: 514 ident: CR28 article-title: Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1318807111 – volume: 32 start-page: 3601 year: 2012 end-page: 3611 ident: CR44 article-title: The microtubule-stabilizing agent, epothilone d, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4922-11.2012 – volume: 110 start-page: 9535 year: 2013 end-page: 9540 ident: CR15 article-title: Brain homogenates from human tauopathies induce tau inclusions in mouse brain publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1301175110 – volume: 177 start-page: 1977 year: 2010 end-page: 1988 ident: CR24 article-title: Aβ accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model publication-title: Am J Pathol doi: 10.2353/ajpath.2010.100346 – volume: 63 start-page: 844 year: 1983 end-page: 914 ident: CR19 article-title: Nucleus locus ceruleus: new evidence of anatomical and physiological specificity publication-title: Physiol Rev – volume: 11 start-page: 909 year: 2009 end-page: 913 ident: CR16 article-title: Transmission and spreading of tauopathy in transgenic mouse brain publication-title: Nat Cell Biol doi: 10.1038/ncb1901 – volume: 123 start-page: 787 year: 2012 end-page: 805 ident: CR40 article-title: Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau publication-title: Acta Neuropathol doi: 10.1007/s00401-012-0987-3 – volume: 42 start-page: 33 year: 2003 end-page: 84 ident: CR6 article-title: The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes publication-title: Brain Res Brain Res Rev doi: 10.1016/S0165-0173(03)00143-7 – volume: 121 start-page: 171 year: 2011 end-page: 181 ident: CR10 article-title: The pathological process underlying Alzheimer’s disease in individuals under thirty publication-title: Acta Neuropathol doi: 10.1007/s00401-010-0789-4 – volume: 127 start-page: 667 year: 2014 end-page: 683 ident: CR1 article-title: A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1254-6 – volume: 13 start-page: 1526 year: 2010 end-page: 1533 ident: CR13 article-title: Tuning arousal with optogenetic modulation of locus coeruleus neurons publication-title: Nat Neurosci doi: 10.1038/nn.2682 – volume: 2 start-page: 113 year: 1979 end-page: 168 ident: CR32 article-title: Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems publication-title: Annu Rev Neurosci doi: 10.1146/annurev.ne.02.030179.000553 – volume: 7 start-page: e31302 year: 2012 ident: CR30 article-title: Trans-synaptic spread of tau pathology in vivo publication-title: PLoS One doi: 10.1371/journal.pone.0031302 – volume: 4 start-page: 519 year: 1979 end-page: 534 ident: CR33 article-title: Raphe projections to the locus coeruleus in the rat publication-title: Brain Res Bull doi: 10.1016/0361-9230(79)90037-6 – volume: 293 start-page: 711 year: 2001 end-page: 714 ident: CR42 article-title: Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles publication-title: Science doi: 10.1126/science.1062382 – volume: 4 start-page: 497 year: 1979 end-page: 504 ident: CR17 article-title: Afferent projections to the self-stimulation regions of the dorsal pons, including the locus coeruleus, in the rat as demonstrated by the horseradish peroxidase technique publication-title: Brain Res Bull doi: 10.1016/0361-9230(79)90034-0 – volume: 73 start-page: 83 year: 2015 end-page: 95 ident: CR37 article-title: Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2014.08.032 – volume: 20 start-page: 130 year: 2014 end-page: 138 ident: CR21 article-title: Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases publication-title: Nat Med doi: 10.1038/nm.3457 – volume: 53 start-page: 337 year: 2007 end-page: 351 ident: CR43 article-title: Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model publication-title: Neuron doi: 10.1016/j.neuron.2007.01.010 – volume: 286 start-page: 15317 year: 2011 end-page: 15331 ident: CR23 article-title: Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles publication-title: J Biol Chem doi: 10.1074/jbc.M110.209296 – volume: 56 start-page: 343 year: 1982 end-page: 356 ident: CR41 article-title: Plaques, tangles and dementia. A quantitative study publication-title: J Neurol Sci doi: 10.1016/0022-510X(82)90155-1 – ident: CR36 – volume: 16 start-page: 109 year: 2015 end-page: 120 ident: CR12 article-title: Spreading of pathology in neurodegenerative diseases: a focus on human studies publication-title: Nat Rev Neurosci doi: 10.1038/nrn3887 – volume: 8 start-page: 663 year: 2007 end-page: 672 ident: CR5 article-title: Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders publication-title: Nat Rev Neurosci doi: 10.1038/nrn2194 – volume: 70 start-page: 960 year: 2011 end-page: 969 ident: CR11 article-title: Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0b013e318232a379 – volume: 65 start-page: 119 year: 1995 end-page: 160 ident: CR31 article-title: Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin publication-title: Neuroscience doi: 10.1016/0306-4522(94)00481-J – volume: 799 start-page: 156 year: 1998 end-page: 158 ident: CR7 article-title: Duration of neurofibrillary changes in the hippocampal pyramidal neurons publication-title: Brain Res doi: 10.1016/S0006-8993(98)00441-7 – volume: 129 start-page: 469 year: 2015 end-page: 491 ident: CR26 article-title: Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1380-1 – volume: 42 start-page: 631 year: 1992 end-page: 639 ident: CR2 article-title: Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease publication-title: Neurology doi: 10.1212/WNL.42.3.631 – volume: 234 start-page: 734 year: 1986 end-page: 737 ident: CR4 article-title: The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network publication-title: Science doi: 10.1126/science.3775363 – volume: 82 start-page: 239 year: 1991 end-page: 259 ident: CR9 article-title: Neuropathological staging of Alzheimer-related changes publication-title: Acta Neuropathol doi: 10.1007/BF00308809 – volume: 52 start-page: 6960 year: 2013 ident: 1458_CR34 publication-title: Biochemistry doi: 10.1021/bi400866w – volume: 129 start-page: 875 year: 2015 ident: 1458_CR39 publication-title: Acta Neuropathol doi: 10.1007/s00401-015-1413-4 – volume: 13 start-page: 1526 year: 2010 ident: 1458_CR13 publication-title: Nat Neurosci doi: 10.1038/nn.2682 – volume: 111 start-page: 510 year: 2014 ident: 1458_CR28 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1318807111 – volume: 28 start-page: 403 year: 2005 ident: 1458_CR3 publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.28.061604.135709 – volume: 70 start-page: 960 year: 2011 ident: 1458_CR11 publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0b013e318232a379 – volume: 2 start-page: 113 year: 1979 ident: 1458_CR32 publication-title: Annu Rev Neurosci doi: 10.1146/annurev.ne.02.030179.000553 – volume: 42 start-page: 631 year: 1992 ident: 1458_CR2 publication-title: Neurology doi: 10.1212/WNL.42.3.631 – volume: 675 start-page: 183 year: 1995 ident: 1458_CR27 publication-title: Brain Res doi: 10.1016/0006-8993(95)00061-T – volume: 11 start-page: 909 year: 2009 ident: 1458_CR16 publication-title: Nat Cell Biol doi: 10.1038/ncb1901 – volume: 177 start-page: 1977 year: 2010 ident: 1458_CR24 publication-title: Am J Pathol doi: 10.2353/ajpath.2010.100346 – volume: 82 start-page: 239 year: 1991 ident: 1458_CR9 publication-title: Acta Neuropathol doi: 10.1007/BF00308809 – volume: 20 start-page: 130 year: 2014 ident: 1458_CR21 publication-title: Nat Med doi: 10.1038/nm.3457 – volume: 123 start-page: 787 year: 2012 ident: 1458_CR40 publication-title: Acta Neuropathol doi: 10.1007/s00401-012-0987-3 – volume: 63 start-page: 844 year: 1983 ident: 1458_CR19 publication-title: Physiol Rev doi: 10.1152/physrev.1983.63.3.844 – volume: 129 start-page: 221 year: 2015 ident: 1458_CR8 publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1373-0 – volume: 16 start-page: 109 year: 2015 ident: 1458_CR12 publication-title: Nat Rev Neurosci doi: 10.1038/nrn3887 – volume: 32 start-page: 3601 year: 2012 ident: 1458_CR44 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4922-11.2012 – volume: 7 start-page: e31302 year: 2012 ident: 1458_CR30 publication-title: PLoS One doi: 10.1371/journal.pone.0031302 – volume: 284 start-page: 12845 year: 2009 ident: 1458_CR20 publication-title: J Biol Chem doi: 10.1074/jbc.M808759200 – volume: 286 start-page: 15317 year: 2011 ident: 1458_CR23 publication-title: J Biol Chem doi: 10.1074/jbc.M110.209296 – volume: 121 start-page: 171 year: 2011 ident: 1458_CR10 publication-title: Acta Neuropathol doi: 10.1007/s00401-010-0789-4 – volume: 4 start-page: 497 year: 1979 ident: 1458_CR17 publication-title: Brain Res Bull doi: 10.1016/0361-9230(79)90034-0 – volume: 65 start-page: 119 year: 1995 ident: 1458_CR31 publication-title: Neuroscience doi: 10.1016/0306-4522(94)00481-J – volume: 56 start-page: 343 year: 1982 ident: 1458_CR41 publication-title: J Neurol Sci doi: 10.1016/0022-510X(82)90155-1 – volume: 53 start-page: 337 year: 2007 ident: 1458_CR43 publication-title: Neuron doi: 10.1016/j.neuron.2007.01.010 – volume: 309 start-page: 476 year: 2005 ident: 1458_CR38 publication-title: Science doi: 10.1126/science.1113694 – volume: 73 start-page: 685 year: 2012 ident: 1458_CR18 publication-title: Neuron doi: 10.1016/j.neuron.2011.11.033 – volume: 24 start-page: 1121 year: 2001 ident: 1458_CR29 publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.24.1.1121 – ident: 1458_CR36 – volume: 33 start-page: 1024 year: 2013 ident: 1458_CR25 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2642-12.2013 – volume: 234 start-page: 734 year: 1986 ident: 1458_CR4 publication-title: Science doi: 10.1126/science.3775363 – volume: 4 start-page: 519 year: 1979 ident: 1458_CR33 publication-title: Brain Res Bull doi: 10.1016/0361-9230(79)90037-6 – volume: 799 start-page: 156 year: 1998 ident: 1458_CR7 publication-title: Brain Res doi: 10.1016/S0006-8993(98)00441-7 – volume: 587 start-page: 717 year: 2013 ident: 1458_CR22 publication-title: FEBS Lett doi: 10.1016/j.febslet.2013.01.051 – volume: 73 start-page: 83 year: 2015 ident: 1458_CR37 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2014.08.032 – volume: 129 start-page: 469 year: 2015 ident: 1458_CR26 publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1380-1 – volume: 178 start-page: 1 year: 1978 ident: 1458_CR14 publication-title: J Comp Neurol doi: 10.1002/cne.901780102 – volume: 58 start-page: 188 year: 1999 ident: 1458_CR35 publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199902000-00008 – volume: 293 start-page: 711 year: 2001 ident: 1458_CR42 publication-title: Science doi: 10.1126/science.1062382 – volume: 8 start-page: 663 year: 2007 ident: 1458_CR5 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2194 – volume: 42 start-page: 33 year: 2003 ident: 1458_CR6 publication-title: Brain Res Brain Res Rev doi: 10.1016/S0165-0173(03)00143-7 – volume: 127 start-page: 667 year: 2014 ident: 1458_CR1 publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1254-6 – volume: 110 start-page: 9535 year: 2013 ident: 1458_CR15 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1301175110 – reference: 22365544 - Neuron. 2012 Feb 23;73(4):685-97 – reference: 19282288 - J Biol Chem. 2009 May 8;284(19):12845-52 – reference: 1759558 - Acta Neuropathol. 1991;82(4):239-59 – reference: 24033133 - Biochemistry. 2013 Oct 8;52(40):6960-7 – reference: 25862635 - Acta Neuropathol. 2015 Jun;129(6):875-94 – reference: 22532069 - Acta Neuropathol. 2012 Jun;123(6):787-805 – reference: 23690619 - Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40 – reference: 9666111 - Brain Res. 1998 Jul 13;799(1):156-8 – reference: 24531916 - Acta Neuropathol. 2014 May;127(5):667-83 – reference: 226233 - Brain Res Bull. 1979 Jul-Aug;4(4):519-34 – reference: 7753394 - Neuroscience. 1995 Mar;65(1):119-60 – reference: 16022602 - Annu Rev Neurosci. 2005;28:403-50 – reference: 25549971 - Acta Neuropathol. 2015 Apr;129(4):469-91 – reference: 3775363 - Science. 1986 Nov 7;234(4777):734-7 – reference: 17270732 - Neuron. 2007 Feb 1;53(3):337-51 – reference: 11520930 - Annu Rev Neurosci. 2001;24:1121-59 – reference: 24504409 - Nat Med. 2014 Feb;20(2):130-8 – reference: 632368 - J Comp Neurol. 1978 Mar 1;178(1):1-16 – reference: 11408621 - Science. 2001 Jul 27;293(5530):711-4 – reference: 23395797 - FEBS Lett. 2013 Mar 18;587(6):717-23 – reference: 21037585 - Nat Neurosci. 2010 Dec;13(12):1526-33 – reference: 22002422 - J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9 – reference: 20802182 - Am J Pathol. 2010 Oct;177(4):1977-88 – reference: 7796127 - Brain Res. 1995 Mar 27;675(1-2):183-9 – reference: 25220759 - Neurobiol Dis. 2015 Jan;73:83-95 – reference: 19503072 - Nat Cell Biol. 2009 Jul;11(7):909-13 – reference: 231924 - Annu Rev Neurosci. 1979;2:113-68 – reference: 10029101 - J Neuropathol Exp Neurol. 1999 Feb;58(2):188-97 – reference: 6308694 - Physiol Rev. 1983 Jul;63(3):844-914 – reference: 17684513 - Nat Rev Neurosci. 2007 Sep;8(9):663-72 – reference: 25588378 - Nat Rev Neurosci. 2015 Feb;16(2):109-20 – reference: 25534024 - Acta Neuropathol. 2015 Feb;129(2):221-37 – reference: 12668290 - Brain Res Brain Res Rev. 2003 Apr;42(1):33-84 – reference: 487203 - Brain Res Bull. 1979 Jul-Aug;4(4):497-504 – reference: 7175555 - J Neurol Sci. 1982 Nov;56(2-3):343-56 – reference: 21372138 - J Biol Chem. 2011 Apr 29;286(17):15317-31 – reference: 21170538 - Acta Neuropathol. 2011 Feb;121(2):171-81 – reference: 1549228 - Neurology. 1992 Mar;42(3 Pt 1):631-9 – reference: 16020737 - Science. 2005 Jul 15;309(5733):476-81 – reference: 23325240 - J Neurosci. 2013 Jan 16;33(3):1024-37 – reference: 22423084 - J Neurosci. 2012 Mar 14;32(11):3601-11 – reference: 24368848 - Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):510-4 – reference: 22312444 - PLoS One. 2012;7(2):e31302 |
SSID | ssj0012745 |
Score | 2.543456 |
Snippet | Filamentous tau inclusions are hallmarks of Alzheimer’s disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the... Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and other neurodegenerative tauopathies. An increasing number of studies implicate the... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 349 |
SubjectTerms | Afferent Pathways - metabolism Afferent Pathways - pathology Alzheimer's disease Analysis Animals Brain Disease Models, Animal Disease Progression Efferent Pathways - metabolism Efferent Pathways - pathology Escherichia coli Female Genetic engineering Humans Hypothalamus - metabolism Hypothalamus - pathology Immunohistochemistry Injections Locus Coeruleus - metabolism Locus Coeruleus - pathology Male Medicine Medicine & Public Health Mice, Transgenic Mutation Neurodegeneration Neurons Neurons - pathology Neurosciences Original Paper Pathology Propagation tau Proteins - genetics tau Proteins - metabolism Tauopathies - metabolism Tauopathies - pathology Thalamus - metabolism Thalamus - pathology Transgenic animals Tyrosine 3-Monooxygenase - metabolism |
SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1taxQxEA56BfFLfberVUYQfGPLJtm3-3gcrUWrCF6hflqSbIKnx650d5H6yb_hz_Av-Uuc2Td6hxb67Y5Mks3Ok5nJzmSGsaeKWxWEiuNOs4Ef5mHq64QSucYWNYpETKk22-f7-PA4fHMSnfT3uKsh2n1wSbaSerzsRnijo2_k8zBK_fAq24rofDJhW7PXn97uj84DPGh1hQuQPEbADs7Mfw2ypo42hfI5rbQZMbnhNm210cENthjW0QWhfN1rar1nfmykeLzkQm-y7d46hVkHp1vsii1us2vvev_7HfZ7oRqgIsbtx3jAgREisCzgw0c-hRoba9J9CMqlASp0Dw5xVn7H6QG1ZlOBKe1ps7L46_nR_AV2_dLGghUVlA6qswLtUZy7HcrRbYRVBcsK8j5ox-agzwBp4Gj-5-evClRX3qUGVeRghz-Gone6Ye-y44P9xfzQ74s--CYJ4trnNhbORC6Mc7Q8cBFc45EIEZVoxU0ilM6lk7lxkiuD3I0F15YrJ4WVSWCVvMcmRVnYHQZGapG6PEaT06KoctPUCi2UUNaRu5l7LBh4n5k-IzoV5lhlYy7nlhUZsiIjVmShx16OXb516UAuIn5GgMpIVOC4RvU3HvDpKOlWNiMnLJpwU-mx3TVK3OJmvXmAZNaLmCqjPEhU1F7iPE_GZupJYXOFLZuOJqGPEBfS4IZJKE-dx-53KB-XJqhcANo5HkvW8D8SUHLy9ZZi-blNUh6SaZ5GHns1gPzco__vjT24FPVDdl3QLmkj_nbZpD5t7CM0EWv9uBcJfwH8x16o priority: 102 providerName: Springer Nature |
Title | Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections |
URI | https://link.springer.com/article/10.1007/s00401-015-1458-4 https://www.ncbi.nlm.nih.gov/pubmed/26150341 https://www.proquest.com/docview/1705400734 https://www.proquest.com/docview/1705733834 https://www.proquest.com/docview/1712774451 https://pubmed.ncbi.nlm.nih.gov/PMC4545685 |
Volume | 130 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1432-0533 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012745 issn: 0001-6322 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1432-0533 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0012745 issn: 0001-6322 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1432-0533 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0012745 issn: 0001-6322 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1432-0533 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012745 issn: 0001-6322 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1432-0533 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0012745 issn: 0001-6322 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rb9MwELdgkxBfEG8yxnRISOOhiNh59hMqVccEY5pglcqnyHFs0alKxpII7a_iX-TOebBUop_axo_EvZ99Z9_ld4y9klxLL5AcZ5r23CAPEjeLicg10qhRfMSUtGyfp9HxIvi8DJfdgVvVhVX2a6JdqPNS0Rn5e6J9oRzefvDh8pdLWaPIu9ql0LjNdjmaKoTqeDlsuDjuuNoMBrhljhC5vVfTa0lE7UY6dHkQJm4w0kubq_MN9bQZOrnhP7Vq6eg-u9fZkzBtAfCA3dLFQ3bna-cxf8T-nMsGKO2wPT4H7AaFCqsCzr7zCdRYWJO2QhitFFBqejCIjPI33gxQzzUVqFJfNWuN316fzN5g0wsbvVVUUBqorgu0IPHetitD7w-sK1hVkHdhNjqH7BqwDpzMDiuQbTqWGmSRg-5_KIq2aTt9zBZH8_PZsdslaXBV7EW1y3UkjApNEOVoKeAQeIZbGERAnEmuYiGz3Dd-rozPpUIhRIJnmkvjC-3Hnpb-E7ZTlIV-xkD5mUhMHqGJqFHUZpJokQkppDbkHuYO83oRpapjMKdEGut04F62Uk1RqilJNQ0c9nZoctnSd2yrfEhyT2lqY79Kdm8o4NMRSVY6JacpmlwT32H7o5o4JdW4uEdO2i0JVfoPwA57ORRTSwpzK3TZtHViOjTYWgdxHROvnMOetmAchiaI3h_tEofFI5gOFYhMfFxSrH5aUvGATOkkdNi7HtA3Hv1__9je9oE-Z3cFzTAbkrfPduqrRr9AG67ODuxEPWC7008_vszx8-P89OwbXl2I6V--n0ep |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIQEviG8CA4wEGh-KiD-atA8ITYWpY92ERCf1LTiOLYpKMpZUU_8p-Be5yxdrJfq2t1Y-O3bufHf2XX4H8EJzqwOlOe40G_gqVX0_iQjINbRoUSTKlK7QPo_D0Yn6PO1Nt-B3-y0MpVW2OrFS1Glu6I78HcG-UA1vqT6c_vKpahRFV9sSGrVYHNrlOR7ZivcHH5G_L4XY_zQZjvymqoBvoiAsfW5D4UzPqTBF04Yvkifoc-OUo0RzEwmdpNLJ1DjJtQnRuxE8sVw7KayMAqsljnsFrioZKMLqj6bdAY_jCa-umIBHdOwp2ihqUIOWVgf3ns9Vr--rFTu4bg0umMP1VM21eG1lBvdvwc3Gf2V7tcDdhi2b3YFrR02E_i78megFozLH1XU9w2Fw7WyWsS9f-YCV2FiSdUSxnRn2E7UUcyiJ-Tk-jKFdXRTM5PZsMbf469V4-Bq7_qiyxbKC5Y4Vyww9Vnx2NZSj7xXmBZsVLG3SemzKkiVDGjYe7hZM1-VfSqazlNn2j6HsnnrQe3ByKey7D9tZntmHwIxMRN-lIbqkFkXLDfpWJEILbR2Fo7kHQcui2DSI6VS4Yx53WM8VV2PkakxcjZUHb7oupzVcyCbiXeJ7TKoExzW6-SICZ0egXPEeBWnRxRtID3ZWKFEFmNXmVnLiRgUV8b8N48Hzrpl6UlpdZvNFTRPRJcVGGpTriHDsPHhQC2O3NEHlBNAP8iBaEdOOgMDLV1uy2fcKxFyR697vefC2FegLU__fG3u0eaHP4PpocjSOxwfHh4_hhqDdVqUD7sB2ebawT9B_LJOn1aZl8O2ytcRfkD2CJA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkCZeEN8EBhwSaHwoWmynSfuA0NRRbaxMk9ikvgXHsUVRScaSaupfxTt_HXfOB2sl-ra3Vj47du58d_ZdfsfYK8WNCkLFcaeZwA-zsO-nMQG5RgYtikSZUg7t8zg6OAs_T3qTDfan_RaG0ipbnegUdVZouiPfJdgXquEtw13bpEWc7I8-nv_yqYIURVrbchq1iByZxSUe38oPh_vI69dCjD6dDg_8psKAr-MgqnxuImF1z4ZRhmYOXypP0f_G6cep4joWKs2klZm2kisdoacjeGq4slIYGQdGSRz3BruJk5KUThZPusMex9NeXT0Bj-vYU7QR1aAGMHWH-J7Pw17fD5ds4qpluGIaV9M2V2K3ziSO7rDbjS8Le7Xw3WUbJr_Htr400fr77PepmgOVPHZX94DD4NphmsPJVz6AChsrspQowlMNP1FjgUWpLC7xYYA2dl6CLszFfGbw15vx8C12_eEyx_ISCgvlIkfvFZ_thrL07cKshGkJWZPiYzJIF4A0MB7ulKDqUjAVqDwD0_7RlOlTD_qAnV0L-x6yzbzIzWMGWqaib7MI3VODYmYHfSNSoYQylkLT3GNBy6JEN-jpVMRjlnS4z46rCXI1Ia4mocfedV3Oa-iQdcQ7xPeE1AqOq1XzdQTOjgC6kj0K2KK7N5Ae216iRHWgl5tbyUkadVQm_zaPx152zdSTUuxyU8xrmpguLNbSoFzHhGnnsUe1MHZLE1RaAH0ij8VLYtoREJD5cks-_e4AzUNy4_s9j71vBfrK1P_3xp6sX-gLtoX6IRkfHh89ZbcEbTaXGbjNNquLuXmGrmSVPnd7Fti361YSfwHAvoZf |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tau+pathology+spread+in+PS19+tau+transgenic+mice+following+locus+coeruleus+%28LC%29+injections+of+synthetic+tau+fibrils+is+determined+by+the+LC%27s+afferent+and+efferent+connections&rft.jtitle=Acta+neuropathologica&rft.au=Iba%2C+Michiyo&rft.au=McBride%2C+Jennifer+D&rft.au=Guo%2C+Jing+L&rft.au=Zhang%2C+Bin&rft.date=2015-09-01&rft.eissn=1432-0533&rft.volume=130&rft.issue=3&rft.spage=349&rft_id=info:doi/10.1007%2Fs00401-015-1458-4&rft_id=info%3Apmid%2F26150341&rft.externalDocID=26150341 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-6322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-6322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-6322&client=summon |